Tag: vaccines

ORWELLIAN CONTROL MACHINE: Again, CDC screaming for everyone to mask up on flights to flatten new Covid curve and push clot-shot VACCINATIONS

The CDC, Centers for Disease Continuance, will push propaganda to the limits in order to coerce the populace into getting jabbed up with any toxic concoction they dream up. It’s lab to jab, with no science to back up the “safe and effective” claims they’ve been spewing for 75 years. Now they want everybody wearing face diapers on all flights so that we’ll all believe that deadly Covid variants are floating on those aerosol particles and infecting the world, again, so we’ll all dash to the doc-in-tha-box and get stuck in the arm with the deadliest jabs ever created. Rinse and repeat.

  • No Return to Mask Mandates Expected: Despite purported rising COVID-19 hospitalizations, public health experts and airlines confirm that mask requirements for air travel are unlikely to return, even as colder weather increases respiratory virus risks and the CDC pushes their propaganda again
  • CDC’s Authority and Industry Pushback: The CDC’s 2021 mask mandate for transportation was struck down by a federal judge for overreach, and airlines have since maintained optional policies. Industry leaders oppose reinstating mandates, calling them ineffective and burdensome.
  • Current CDC Guidance Focuses on Localized Risks: The CDC now ties mask recommendations to regional hospitalization levels — currently low in 92% of the U.S. — and denies rumors of impending federal mandates, emphasizing voluntary precautions instead.
  • Public Sentiment and Pandemic Shifts Make Mandates Unlikely: Experts cite reduced pandemic severity and widespread resistance to masking as barriers to renewed mandates, though some high-risk settings (e.g., hospitals, schools) may still enforce them locally.

Keep reading

mRNA Shots Induce Cancer-Linked Bone Marrow Reprogramming Within Weeks

The study titled, Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration, was just published in Current Molecular Medicine.

Researchers analyzed bone marrow samples from three groups using untargeted metabolomics, a powerful technique that detects thousands of small molecules reflecting real-time cellular activity:

  1. Vaccinated leukemia patients (n=7) — all of whom developed leukemia within 15 to 63 days after receiving Pfizer’s BNT162b2 COVID-19 mRNA injection
  2. Unvaccinated leukemia patients with no history of COVID-19 (n=2)
  3. Healthy, unvaccinated individuals (n=7)

Here’s what they found:

As expected, the metabolic profiles of both leukemia groups were markedly different from healthy controls—showing classic cancer-linked changes like:

  • ↑ Glycolysis (sugar breakdown)
  • ↑ Pentose phosphate pathway (nucleotide synthesis and redox balance)
  • Altered tryptophan metabolism, known to create an immunosuppressive tumor environment
  • Disrupted heme metabolism, involved in red blood cell formation and oxidative stress

However, the vaccinated leukemia group showed additional, distinct metabolic alterations that were not present in unvaccinated leukemia patients, including:

  • ↑ Tetrahydrofolic acid — vital for DNA synthesis, repair, and methylation. Uniquely elevated in vaccinated leukemia patients, possibly reflecting folate cycle modulation or compensatory changes in nucleotide metabolism.
  • ↑ Phosphorylcholine — a marker of altered membrane metabolism, linked to tumor progression, lipid signaling, and immune activation. Elevated only in vaccinated leukemia patients, contrasting with a decrease in unvaccinated leukemia cases.
  • ↑ N-Formyl-L-glutamic acid / N-Acetyl-L-aspartic acid — involved in amino acid and mitochondrial metabolism. Significantly elevated in vaccinated leukemia patients, not seen in unvaccinated leukemia individuals.
  • ↑ Delta 8.14-Sterol — a sterol lipid involved in membrane structure and cellular signaling. Increased only in the vaccinated leukemia group, potentially indicating vaccine-induced disruption of lipid regulation.

All seven vaccinated leukemia patients developed cancer within two months of mRNA injection.

Keep reading

The Nuremberg Code And The Vaccine Mandate For Service Members

The Nuremberg Trials were an attempt to bring justice to the Nazis for some of the most reprehensible criminal acts of World War II. One subset of those trials was known as “The Doctors’ Trial,” so named because it prosecuted some 23 distinguished medical scientists and physicians charged with murder and unspeakable torture through medical experimentation on concentration camp prisoners.

One of the most important outcomes of that trial—aside from meting out justice to the medical monsters—was the establishment of the Nuremberg Code, which offered a 10-point statement outlining proper limits on human experimentation moving forward. It proclaimed that such experimentation is justified only when the participation is voluntary, when the results benefit society, and when it is conducted in accord with basic principles that “satisfy moral, ethical, and legal concepts.” It memorialized what most decent people would have thought was already common sense and practice for a civilized society.

Notwithstanding the proscriptions of the Nuremberg Code, the Department of Defense authorized the use of unlicensed medications in the first Gulf War. Specifically, DoD obtained informed consent waivers from the FDA to allow the involuntary administration of unlicensed medications as a prophylactic against potential Iraqi chemical and biological weapons.

These medications were postulated by some medical professionals as a cause of so-called Gulf War Syndrome. In light of this, Congress passed a specific prohibition on the use of unlicensed medications on Service Members without their informed consent. The statute, codified at 10 USC §1107, requires informed consent from a Service Member before the administration of an unlicensed medication. Only the president can waive this requirement by ordering a waiver of informed consent in certain exigencies.

The statute got its first test when a federal court shut down DoD’s involuntary anthrax vaccination program in 2004 after a judge determined the anthrax vaccine had not been properly licensed by the FDA for use in a military context.

But nearly 20 years later, our country again flirted with violation of this statute and the Code as it mandated experimental COVID-19 vaccines for our Service Members. That injustice has yet to be fully addressed. Over 8,000 active-duty Service Members were involuntarily separated after failing to receive a religious exemption or other accommodation from the vaccine mandate and then refused to get vaccinated after being ordered to do so.

Keep reading

An Evidence-Based Approach to Covid-19 Vaccination??

‘An Evidence-Based Approach to Covid-19 Vaccination’ is the misleading title of an extraordinary publication by Vinay Prasad and Marty Makary in the New England Journal of Medicine, 20th May 2025. It describes the FDA’s new approach, but if you were hoping for ‘Evidence-Based’ you’ll be sorely disappointed. One could argue that this is a start, in that it does involve withdrawing FDA recommendations for regular boosters for ‘healthy 6 months- to 64 year-olds’ but the state of ‘health’ in the US is so poor that apparently two thirds of Americans are still eligible for the shots. (‘Underlying medical conditions’ include pregnancy, obesity, physical inactivity and smoking, current and former),

The article goes on to describe a requirement for gold standard randomised controlled trials for further vaccines for a healthy population of say 50-64 years with a saline placebo and a 6 month follow-up but again using an end-point related to covid alone rather than all-cause mortality or morbidity. For over-65s or those with comorbidities, only evidence of antibody production is required.

Then on 27th May, a week after the NEJM article, Robert Kennedy, flanked by Jay Battacharia and Marty Makary, announced the changes to the CDC schedule, stating that the vaccines would be withdrawn for healthy under 65s and healthy pregnant women. The statement was somewhat underwhelming, especially Jay Battacharya’s rather wooden performance – another example of the 3-word or 3-phrase mantra: “That ends today. It’s common sense and it’s good science”.

Some cynics were quick to point out that the CDC guidance had not changed, but by 29th May the website was updated though not in quite the way I had anticipated from RFK’s words. The covid vaccine for children now states ‘See notes’ and then outlines a system of ‘shared clinical decision-making’ as follows: “Shared clinical decision-making vaccinations are individually based and informed by a decision process between the health care provider and the patient or parent/guardian. Where the parent presents with a desire for their child to be vaccinated, children 6 months and older may receive COVID-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances.” Only for children with moderate or severe immunocompromise does the CDC actively advise a booster. So for children this actually goes further than the Prasad and Makary article, leaving only immunocompromise as a co-morbidity for recommended covid boosters in under 18s, in line with the current UK guidelines. The Children’s Health Defence have tried to explain the very opaque guidelines – one plus would be that paediatricians would no longer be obliged to recommend the vaccines – at present they risk losing their tenure if they speak out against the jabs. But for adults, there appears to be no change with covid vaccines still recommended as routine including during pregnancy.

Keep reading

Meet the Bureaucrats Who Hid Data About Heart Damage from the mRNA COVID Vaccines

One hundred and eleven people, including 100 U.S. government employees, were involved in the Biden Administration’s myocarditis cover-up that attorney Ed Berkovich uncovered through Freedom of Information Act (FOIA) email productions. Those emails and the cover-up were the subject of Senator Ron Johnson’s May 22, 2025, “The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events Associated with the COVID-19 Vaccines” hearing and the associated “Failure to Warn: How Federal Health Agencies Downplayed the Risk of Myocarditis and Other Adverse Events Following COVID-19 Vaccination” report.

Mr. Berkovich submitted a FOIA request to the Centers for Disease Control and Prevention (CDC) stating, “I request emails sent by and received by Dr. Rochelle P. Walensky, Sherri A. Berger, and Kevin Griffis (all of whom are CDC personnel) on dates beginning February 1, 2021 through May 31, 2021, containing the word myocarditis.” DailyClout reported on the subsequent FOIA productions, which first revealed the CDC’s delayed action:

This WarRoom/DailyClout reporting revealed publicly for the first time:

  • CDC Internal Awareness of Myocarditis: The FOIA-obtained emails show that CDC officials knew about COVID-19 mRNA vaccine-associated myocarditis as early as February 19, 2021, less than three months after the vaccines became publicly available.
  • Health Alert Not Issued: The CDC had internal deliberations regarding issuing a health advisory alert via its Health Alert Network (HAN) and ultimately did not issue one.
  • Public Communication Delay: Despite months of internal discussions about cases of myocarditis associated with mRNA COVID-19 vaccines, the CDC’s public acknowledgment of myocarditis risk occurred on May 27, 2021, three months after the CDC first became aware of it.

For the first time, the full list of the 111 people, including the 100 government employees, involved in the communications related to the myocarditis cover-up, is publicly available. The job titles and hyperlinks included were all accurate and active as of November 2024.

Keep reading

Despite Cancellation of Moderna’s mRNA Bird Flu Jab, Efforts for mRNA-LNP H5N1 Jab for Cattle Forges Ahead

Citing a decision based on safety, integrity, and trust connected to a product that “was not scientifically or ethically justifiable,” the US Department of Health and Human Services (HHS) notified Moderna on May 28 that it was terminating the company’s $776 million contract for the development of a bird flu vaccine for humans. That decision is undoubtedly the correct decision. Yet, meanwhile, realizing the danger to humans of the under-tested mRNA technology platform, the US government continues to fund research on H5 influenza mRNA-lipid nanoparticle (LNP) vaccines for use in cattle.

And to make matters worse—and essentially negate the progress made with the termination of HHS’s contract with Moderna—the US Food and Drug Administration (FDA) approved on May 31 a new Moderna COVID-19 mRNA jab called mNEXSPIKE®, which the DARPA partner noted was “for use in all adults 65 and older, as well as individuals 12 through 64 years of age with at least one underlying condition that put them at high risk for severe outcomes from COVID-19.”

While this article ponders the ongoing experimentation with mRNA technology in cattle for bird flu, the FDA’s approval of mNEXSPIKE® is reckless. Meanwhile, as we discuss cattle, the National Institutes of Health (NIH), the US Department of Agriculture (USDA), and the US Department of Energy continue to use federal funding to create mRNA-LNP jabs targeting highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b in Holstein calves. The USDA allocated $824 million in emergency funding in May 2024 to bolster H5N1 efforts, including vaccine development for livestock, with ongoing research to evaluate effectiveness in lactating dairy cattle and eventually other animal species.

To help push the needle forward quickly, a 2025 preprint conducted by researchers at the USDA’s National Animal Disease Center and the University of Pennsylvania—who have received consulting fees from Big Pharma groups, including Pfizer—aims to paint the research in a glowing light, noting that an H5 mRNA-LNP vaccine induced robust antibody and T-cell responses in calves, offering partial protection against H5N1. However, notably, the preprint failed to report biodistribution data, only mentioning intramuscular administration but not whether the mRNA or LNPs were tracked in tissues beyond the intramuscular injection site. But make no mistake. We know that both the mRNA and toxic LNPs can also enter the bloodstream, leading to systemic distribution to organs across the body, including the liver, spleen, heart, and other tissues.

Concerningly, we also know mRNA-LNPs cross the blood-brain barrier, settling into essentially every organ in the human body, causing damage to the brain, heart, liver, and bone marrow in humans. Why isn’t this deadly hazard being studied in cattle? Thus far, no studies have directly quantified H5 mRNA-LNP biodistribution in cattle, particularly in lactating dairy cows, where H5N1 replication in the mammary glands raises significant concerns about milk safety.

Keep reading

Vaccines May Trigger Sudden Infant Death Syndrome via Brainstem Failure

The study titled, The Immature Infant Liver: Cytochrome P450 Enzymes and their Relevance to Vaccine Safety and SIDS Research, was just published in the International Journal of Medical Sciences.

This comprehensive paper indicates that many infants can not safely tolerate routine vaccination schedules. By integrating pharmacogenetics, toxicology, and epidemiological evidence—including a detailed review of cytochrome P450 enzyme maturation, genetic polymorphisms, vaccine excipient toxicity, and post-vaccination death timing from VAERS—the authors show that underdeveloped liver enzyme systems may leave certain infants unable to detoxify vaccine components. The result is a biologically plausible mechanism linking early-life vaccination to sudden infant death, particularly in those with genetic or developmental vulnerabilities.

Keep reading

Vascular and organ damage induced by mRNA vaccines: irrefutable proof of causality

This article summarizes evidence from experimental studies and from autopsies of patients deceased after vaccination. The collective findings demonstrate that

  1. mRNA vaccines don’t stay at the injection site by instead travel throughout the body and accumulate in various organs,
  2. mRNA-based COVID vaccines induce long-lasting expression of the SARS-CoV-2 spike protein in many organs,
  3. vaccine-induced expression of the spike protein induces autoimmune-like inflammation,
  4. vaccine-induced inflammation can cause grave organ damage, especially in vessels, sometimes with deadly outcome.

We note that the damage mechanism is which emerges from the autopsy studies is not limited to COVID-19 vaccines only but is completely general—it must be expected to occur similarly with mRNA vaccines against any and all infectious pathogens. This technology has failed and must be abandoned.

While clinical case reports (e.g. [1,2]) and statistical analyses of accumulated adverse event reports (e.g. [3,4]) provide valuable evidence of damage induced by mRNA-based COVID-19 vaccines, it is important to establish a causal relationship in individual cases. Pathology remains the gold standard for proof of disease causation. This short paper will discuss some key findings on autopsy materials from patients who died within days to several months after vaccination. For context, some experimental studies are briefly discussed as well.

Keep reading

FBI’s investigation on COVID coverup zeroing in on three separate plots

Asprawling FBI investigation into possible criminal coverups during the COVID-19 pandemic is zeroing in on three separate plots involving the origins of the virus; the hiding and destruction of federal records; and the manipulation of the vaccine approval process and subsequent side effects.

Agents in at least three cities — Cleveland, New York, and Baltimore — are working quickly in the investigation. The investigation was given a legal springboard in a major court ruling holding that China concealed the origins of the COVID-19 virus as well as recent information uncovered by Congress.

The existence of the sprawling investigation was made public last week by FBI Deputy Director Dan Bongino, who described the probe generally in a social media post.

“As we read and process reports of a new COVID strain emerging, I want you to know that we are actively investigating, in multiple field offices, the cover-up of the origin of the COVID virus, along with associated matters requiring our attention,” Bongino wrote in his X account. “You deserve answers.”

Some of the evidence driving the most active parts of the investigation includes emails in which federal scientists admit they were trying to hide discussions about COVID and the vaccine from the public by using private emails.

The possibility of illegal conduct in that matter is being led by agents in Baltimore, officials told Just the News. 

Concerns and related evidence that federal scientists may have tried to hide elements of COVID’s emergence in Wuhan, China because of its own research there are being led by agents in Cleveland, officials added.

There is now open-source intelligence suggesting the earliest recorded case of COVID in China’s databases may have been in September 2019 and that several scientists at the Wuhan Institute of Virology were sickened by the virus in October 2019, well before China admitted that there was human transmission of the virus in January 2020.

Keep reading

FDA approves Moderna’s new lower-dose COVID-19 vaccine

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It’s made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.

The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna’s CEO, said in a statement Saturday.

The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus.

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.

Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.

Moderna’s existing vaccine doesn’t face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall.

Keep reading